Insight updating of the molecular hallmarks in ovarian carcinoma

Abstract

Background and purpose Ovarian cancer (OC) is the deadliest gynaecologic cancer characterised by a high heterogeneity not only at the clinical point of view but also at the molecular level. This review focuses on the new insights about the OC molecular classification. Materials and methods We performed a bibliographic search for different indexed articles focused on the new molecular classification of OC. All of them have been published in PubMed and included information about the most frequent molecular alterations in OC confirmed by omics approaches. In addition, we have extracted information about the role of liquid biopsy in the OC diagnosis and prognosis. Results New molecular insights into OC have allowed novel clinical entities to be defined. Among OC, high-grade serous ovarian carcinoma (HGSOC) which is the most common OC is characterised by omics approaches, mutations in TP53 and in other genes involved in the homologous recombination repair, especially BRCA1/2 . Recent studies in HGSOC have allowed a new molecular classification in subgroups according to their mutational, transcriptional, methylation and copy number variation signatures with a real impact in the characterisation of new therapeutic targets for OC to be defined. Furthermore, despite the intrinsic intra-tumour heterogeneity, the advances in next generation sequencing (NGS) analyses of ascetic liquid from OC have opened new ways for its characterisation and treatment. Conclusions The advances in genomic approaches have been used for the identification of new molecular profiling techniques which define OC subgroups and has supposed advances in the diagnosis and in the personalised treatment of OC.

Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care

“…As a consequence, they become particularly sensitive to the inhibition of the HR and DDR pathways [69,70]. In patients with germline BRCA mutations, platinum-based chemotherapy and PARP inhibition increase the chance of cancer cell death [71].…”

Extraterrestrial Gynecology: Could Spaceflight Increase the Risk of Developing Cancer in Female Astronauts? An Updated Review

“…Up to 90% of OCs are of epithelial origin [96]. OC is commonly associated with alterations in BRCA1/2 and TP53, both of which are linked with a poor prognosis [97][98][99]. Typically, the onset is insidious, with no specific clinical symptoms in the early stage of the disease.…”

LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?

“…Up to 90% of OCs are of epithelial origin [38]. OC is commonly associated with alterations in TP53 and BRCA1/2, which are linked with an increased risk of cancer and poor prognosis [51][52][53]. In spite of the great efforts made for early detection of OC and the development of radiotherapy, novel chemotherapy, targeted therapy, and multidisciplinary treatments, there still is five-year overall survival rate of less than 50% patients [54].…”